Spots Global Cancer Trial Database for Comparison of Drug Eluting Stent and Covered Metal Stent in Malignant Biliary Obstruction (MIRA III)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Comparison of Drug Eluting Stent and Covered Metal Stent in Malignant Biliary Obstruction (MIRA III)
Official Title: A Prospective, Randomized, Single Blind Study to Evaluate the Effectiveness and Safety Comparing Niti-S Mira-Cover III Biliary Stent With ComVi Biliary Covered Stent in Patients With Malignant Biliary Obstruction
Study ID: NCT02460432
Study Description
Brief Summary: The purpose of this study is to compare the effectiveness and safety of Niti-S Mira-Cover III Biliary Stent with Comvi Biliary Covered Stent for the treatment of malignant biliary obstruction.
Detailed Description: In patients with malignant biliary obstruction, endoscopic placement of biliary stents offers similar technical success rates. Endoscopic retrograde cholangiography (ERCP)-guided stent placement has become the preferred approach to palliate malignant biliary obstruction. The major mechanisms of self-expandable metallic stent (SEMS) occlusion are tumor ingrowth, tumor overgrowth, and epithelial hyperplasia. These mechanisms provide the rationale for developing a drug-eluting stent in order to improve stent patency. Limited data exist regarding outcomes of paclitaxel-eluting stents in malignant biliary obstruction. This study is to prospectively compare the effectiveness and safety of paclitaxel-eluting covered metal stent and covered metal stent for the treatment of malignant biliary obstruction.
Eligibility
Minimum Age: 19 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Inje University Busan Paik Hospital, Busan, Bokji-ro Busanjin-gu, Korea, Republic of
Seoul National University Hospital, Seoul, Haehak-ro Jongno-gu, Korea, Republic of
In Ha University Hospital, Incheon, Inhang-ro Jung-gu, Korea, Republic of
Samsung Medical Center, Seoul, Irwon-Dong, Gangnam-Gu, Korea, Republic of
Gangnam Severance Hospital, Seoul, , Korea, Republic of
Contact Details
Name: Dong Ki Lee, Ph.D MD
Affiliation: Gangnam Severance Hospital
Role: STUDY_CHAIR
Name: Kyu Taek Lee, Ph.D MD
Affiliation: Samsung Medical Center
Role: PRINCIPAL_INVESTIGATOR
Name: Sang Hyub Lee, Ph.D MD
Affiliation: Seoul National University Hospital
Role: PRINCIPAL_INVESTIGATOR
Name: Don Haeng Lee, Ph.D MD
Affiliation: In Ha University Hospital
Role: PRINCIPAL_INVESTIGATOR
Name: Jung Sik Choi, Ph.D MD
Affiliation: Inje University
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
